BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 12171582)

  • 1. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
    Fournet A; Muñoz V
    Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K
    Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 4. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
    Navarro M; Gabbiani C; Messori L; Gambino D
    Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plants as Antileishmanial Agents: Current Scenario.
    Ullah N; Nadhman A; Siddiq S; Mehwish S; Islam A; Jafri L; Hamayun M
    Phytother Res; 2016 Dec; 30(12):1905-1925. PubMed ID: 27704633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
    Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of natural products with antileishmanial activity.
    Rocha LG; Almeida JR; Macêdo RO; Barbosa-Filho JM
    Phytomedicine; 2005 Jun; 12(6-7):514-35. PubMed ID: 16008131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic compounds from Cornus florida L. with activities against Plasmodium falciparum and Leishmania tarentolae.
    Graziose R; Rojas-Silva P; Rathinasabapathy T; Dekock C; Grace MH; Poulev A; Ann Lila M; Smith P; Raskin I
    J Ethnopharmacol; 2012 Jul; 142(2):456-61. PubMed ID: 22609155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-leishmanial and anti-trypanosomal natural products from endophytes.
    Hzounda Fokou JB; Dize D; Etame Loe GM; Nko'o MHJ; Ngene JP; Ngoule CC; Boyom FF
    Parasitol Res; 2021 Mar; 120(3):785-796. PubMed ID: 33409640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae.
    Koko WS; Al Nasr IS; Khan TA; Schobert R; Biersack B
    Chem Biodivers; 2022 Jan; 19(1):e202100542. PubMed ID: 34822224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and evaluation of Peruvian plants used to treat malaria and leishmaniasis.
    Kvist LP; Christensen SB; Rasmussen HB; Mejia K; Gonzalez A
    J Ethnopharmacol; 2006 Jul; 106(3):390-402. PubMed ID: 16517108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemotherapeutic potential of chalcones against leishmaniases: a review.
    Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA
    Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
    Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents.
    Bekhit AA; Hassan AM; Abd El Razik HA; El-Miligy MM; El-Agroudy EJ; Bekhit Ael-D
    Eur J Med Chem; 2015 Apr; 94():30-44. PubMed ID: 25768697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.
    Cruz AK; de Toledo JS; Falade M; Terrão MC; Kamchonwongpaisan S; Kyle DE; Uthaipibull C
    Curr Drug Targets; 2009 Mar; 10(3):178-92. PubMed ID: 19275555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K
    Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis.
    Werbovetz KA
    Curr Med Chem; 2000 Aug; 7(8):835-60. PubMed ID: 10828290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antiprotozoal and plasmodial enoyl-ACP reductase inhibition potential of turkish medicinal plants.
    Tasdemir D; Brun R; Perozzo R; Dönmez AA
    Phytother Res; 2005 Feb; 19(2):162-6. PubMed ID: 15852483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.